4.5 Article

Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors

Journal

JOURNAL OF MEDICAL GENETICS
Volume -, Issue -, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2021-107904

Keywords

-

Funding

  1. Cancer Research UK [C12292/A20861, PPRPGM-Nov20\100002, A12677, C1479/A2884, C8640/A23385]
  2. Eve Appeal
  3. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  4. Medical Research Council [G9901012, G0801228]
  5. Department of Health
  6. PERSPECTIVE I&I project - Government of Canada through Genome Canada [13529]
  7. Canadian Institutes of Health Research [155865]
  8. Ministere de l'Economie et de l'Innovation du Quebec through Genome Quebec
  9. Quebec Breast Cancer Foundation
  10. CHU de Quebec Foundation
  11. Ontario Research Fund
  12. European Union Seventh Framework Programme (2007-2013)/European Research Council [310018]
  13. MRC [MR_UU_12023]
  14. MRC [G0801228, G9901012] Funding Source: UKRI

Ask authors/readers for more resources

The study developed a multifactorial risk model for epithelial tubo-ovarian cancer in women of European ancestry, which can help identify high-risk individuals and provide assistance for targeted screening and prevention.
Background Epithelial tubo-ovarian cancer (EOC) has high mortality partly due to late diagnosis. Prevention is available but may be associated with adverse effects. A multifactorial risk model based on known genetic and epidemiological risk factors (RFs) for EOC can help identify women at higher risk who could benefit from targeted screening and prevention. Methods We developed a multifactorial EOC risk model for women of European ancestry incorporating the effects of pathogenic variants (PVs) in BRCA1, BRCA2, RAD51C, RAD51D and BRIP1, a Polygenic Risk Score (PRS) of arbitrary size, the effects of RFs and explicit family history (FH) using a synthetic model approach. The PRS, PV and RFs were assumed to act multiplicatively. Results Based on a currently available PRS for EOC that explains 5% of the EOC polygenic variance, the estimated lifetime risks under the multifactorial model in the general population vary from 0.5% to 4.6% for the first to 99th percentiles of the EOC risk distribution. The corresponding range for women with an affected firstdegree relative is 1.9%-10.3%. Based on the combined risk distribution, 33% of RAD51D PV carriers are expected to have a lifetime EOC risk of less than 10%. RFs provided the widest distribution, followed by the PRS. In an independent partial model validation, absolute and relative 5-year risks were well calibrated in quintiles of predicted risk. Conclusion This multifactorial risk model can facilitate stratification, in particular among women with FH of cancer and/or moderate-risk and high-risk PVs. The model is available via the CanRisk Tool (www.canrisk.org).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available